Who are hydrochloric acid's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Acid Reflux Relief, Potassium Iodide, Micro-K 10, IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER, potassium bromide.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/hydrochloric-acid.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

hydrochloric acid — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

hydrochloric acid (hydrochloric acid) competitive landscape: 5 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: hydrochloric acid. Area: Other.

unknown hydrochloric acid Carbonic anhydrase 4 Other Live · refreshed every 30 min

Target snapshot

hydrochloric acid (hydrochloric acid). Hydrochloric acid works by inhibiting the enzyme carbonic anhydrase 4, which plays a role in various physiological processes.

Comparator set (5 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
hydrochloric acid TARGET	hydrochloric acid		unknown	hydrochloric acid	Carbonic anhydrase 4
Acid Reflux Relief	Sodium Phosphate, Dibasic, Heptahydrate	Pfizer	marketed	Non-Standardized Plant Allergenic Extract [EPC]	Carbonic anhydrase 4	1983-01-01
Potassium Iodide	POTASSIUM IODIDE	Roxane	marketed		Carbonic anhydrase 4	1979-01-01
Micro-K 10	POTASSIUM CHLORIDE	Nesher Pharms	marketed	potassium chloride	Carbonic anhydrase 4	1965-01-01
IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER	SODIUM PHOSPHATE, MONOBASIC ANHYDROUS	OTSUKA ICU MEDCL	marketed		Carbonic anhydrase 4
potassium bromide	potassium bromide		marketed		Carbonic anhydrase 4

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2028-06-22 — Acid Reflux Relief · 7687075 · US
2039-03-07 — Micro-K 10 · 12539314 · Formulation · US

Sponsor landscape (hydrochloric acid class)

· 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). hydrochloric acid — Competitive Intelligence Brief. https://druglandscape.com/ci/hydrochloric-acid. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing